Lehrstuhl für Innere Medizin III

Overexpression of transmembrane TNF drives development of ectopic lymphoid structures in the bone marrow and B cell lineage alterations in experimental spondyloarthritis (2021) Kaaij MH, Rip J, Jeucken KC, Kan YY, van Rooijen CC, Saris J, Pots D, et al. Journal article Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial (2021) Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber A, Manger B, et al. Journal article The Transcription Factor FRA-1/AP-1 Controls Lipocalin-2 Expression and Inflammation in Sepsis Model (2021) Cao S, Schnelzer A, Hannemann N, Schett G, Soulat D, Bozec A Journal article Model curriculum of the German society for Rheumatology for advanced training in the discipline internal medicine and rheumatology. English version (2021) Pfeil A, Krusche M, Vossen D, Berliner MN, Keysser G, Krause A, Lorenz HM, et al. Journal article Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease (2021) Haberman RH, Herati RS, Simon D, Samanovic M, Blank RB, Tuen M, Koralov SB, et al. Journal article COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses (2021) Fagni F, Simon D, Tascilar K, Schoenau V, Sticherling M, Neurath M, Schett G Journal article, Review article New Insights into Bone Loss in RA (2021) Andreev D, Bozec A Journal article, Review article Response to secukinumab on synovitis using Power Doppler ultrasound in psoriatic arthritis: 12-week results from a phase III study, ULTIMATE (2021) D'Agostino MA, Schett G, Lopez-Rdz A, Senolt L, Fazekas K, Burgos-Vargas R, Maldonado-Cocco J, et al. Journal article Measuring treatment effect on psoriatic arthritis-related domains: insights from the SPIRIT-H2H study at weeks 24 and 52 (2021) Behrens F, Leage SL, Sapin C, El Baou C, De La Torre I, Meszaros G, Schett G, et al. Journal article Enasidenib in IDH-2 mutant AML patients with relapse after allogeneic stem cell transplantation (2021) Vasova I, Spörl S, Guggenberger V, Berisha M, Rech D, Behzad A, Brandt A, et al. Conference contribution